University of California San Francisco
Give to UCSFUCSF researchers are working on deep-brain stimulation technology that can be customized to the patient’s brain make up and their own brain’s feedback.
Understanding the biological differences that drive distinct symptoms of Alzheimer’s disease could lead to more personalized patient care and potentially therapies targeted to patients’ individual needs.
A low-cost test that screens for excess protein in the urine has been shown to accurately identify patients at higher risk for progressive kidney disease after being hospitalized for acute kidney
Just weeks since the viral illness was first reported in Wuhan, China, health experts globally are working on containing and treating it.To put the latest news in context, we asked UCSF infectious disease expert Charles Chiu, MD, PhD, about the origins of the Wuhan virus and public health risks going forward.
For 15 years, nobody could figure out what was making a young woman so sick. Then neurologist Michael Wilson, MD, tried a radical new test.
In this interview, Keith Yamamoto, PhD, Director of UCSF Precision Medicine, explains why UCSF is considered a leader in the field and describes the "machine" created to fuel new insights and innovation.
UCSF–led research team has discovered the first conclusive evidence that natural selection may also occur at the level of the epigenome and has done so for tens of millions of years.
English and Italian speakers with dementia-related language impairment experience distinct kinds of speech and reading difficulties based on features of their native languages.
A physically and mentally active lifestyle confers resilience to frontotemporal dementia, even in people whose genetic profile makes the eventual development of the disease virtually inevitable.
UCSF postdoctoral researcher for the first time succeeded in keeping a diverse array of glioblastomas alive in the lab using brain organoids
Advances in medicine and public health have dramatically extended the lifespan of hearts, lungs, and other vital organs. But for women, the ovaries remain a stubborn exception. That may soon change, says fertility expert Marcelle Cedars.
With the global population of seniors projected to reach 1.5 billion by 2050, it will be more important than ever to reduce the burden of age-related disease. In the future, science will allow us to intervene in the aging process to make this a reality, according to geriatrician John Newman.
Basic scientist Zena Werb, who has studied cancer cells in UCSF labs for more than four decades, shares her take on the future of cancer medicine.